Answers are grounded in this paper and cite their sources.
Randomized trial demonstrates improved guideline-based care in patients with asthma and COPD, suggesting a viable model for specialty management.
Rationale Socioeconomically disadvantaged patients with asthma and/or chronic obstructive pulmonary disease (COPD) face barriers to evidence-based care that are difficult to overcome in resource-limited settings. We sought to determine the benefit of a pulmonary-specialist-health coach consultation model for patients with asthma and/or COPD compared with usual care. Methods We conducted a randomized controlled trial of 16 weeks of health coach-facilitated pulmonary consultation and support for implementing specialist recommendations versus usual care for adult English- or Spanish-speaking patients. Study sites primarily served low-income, publicly insured individuals. Primary outcomes were receipt of guideline-based care and medications. Secondary outcomes included receipt of chronic lung disease education, breathing-related quality of life and symptoms (St. George’s Respiratory Questionnaire; SGRQ), and adherence to inhaler therapy. Longitudinal models for count data estimated mean relative rates (RRs); parallel models for continuous data estimated relative means (RMs). Results Twelve types of guideline-based care gaps were identified in the 12 months before enrollment. During the intervention period, 23.7% of care gaps were closed for control patients (n = 163) and 38.2% for intervention patients (n = 165), for an overall RR of 1.61 (95% CI, 1.37-1.90). Intervention patients were not significantly more likely to receive guideline-based medications in the planned pooled-baseline analysis; however, a post hoc analysis controlling for baseline by study arm showed significant improvement, with a 3.7% increase for control versus 21.5% for intervention patients. During the intervention period, 55.7% of control patients and 76.5% of intervention patients received chronic lung disease education (RR, 1.37; 95% CI, 1.00-1.88). For breathing-specific quality of life (SGRQ total score 0-100, lower scores = better quality of life), the mean baseline score was 51.2. At 16 weeks, scores were 50.0 for controls and 37.1 for the intervention arm (RM, 0.74; 95% CI, 0.68-0.81). The SGRQ symptom subscale score improved from 55.9 at baseline to 49.2 for controls and 40.5 for the intervention arm (RM, 0.82; 95% CI, 0.78-0.87). No differences were observed in changes in self-reported inhaler adherence across arms. Conclusions A pulmonary-specialist-health coach consultation model significantly improved uptake of guideline-based care and patient-reported outcomes, offering a scalable approach to expand access to specialty-informed chronic lung disease management in resource-limited primary care settings.
No takes yet. Share an insight, caveat, or question.
Su et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: